Boehringer Ingelheim Pharmaceuticals, Inc. / Lilly USA
come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in
areas of high unmet medical need. Founded in 1885 and independently owned ever since, Boehringer Ingelheim
takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two
business units, Human Pharma and Animal Health. Learn more at www.boehringer-ingelheim.com/us.